Related Experiment Video
Updated: Nov 19, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation
Om Prakash Mehta1, Parshal Bhandari2, Akshay Raut3
1Department of Medicine, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan.
Insights
This review details the wide-ranging clinical presentations of COVID-19, including its effects beyond the lungs. Understanding these diverse symptoms aids early diagnosis and disease control.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- COVID-19, identified in December 2019, rapidly became a global pandemic declared by WHO.
- The disease primarily affects the lungs via respiratory droplet transmission but can manifest systemically.
Purpose of the Study:
- To review the extensive literature on COVID-19 clinical presentations across organ systems.
- To examine COVID-19's impact on specific populations and discuss related inflammatory syndromes.
Main Methods:
- Literature review of COVID-19 clinical manifestations.
- Analysis of organ system involvement and specific population data.
Main Results:
- COVID-19 presents with a spectrum from asymptomatic to fatal, affecting multiple organ systems (gastrointestinal, cardiovascular, etc.).
- Extra-pulmonary symptoms are linked to systemic inflammation and ACE2 receptor expression.
- Clinical presentations vary in children, pregnant women, and immunocompromised individuals.
Conclusions:
- Early diagnosis of COVID-19 is facilitated by understanding its diverse clinical presentations.
- Awareness of multisystem involvement is crucial for effective patient management and disease prevention.
Abstract:
COVID-19 is a rapidly growing pandemic with its first case identified during December 2019 in Wuhan, Hubei Province, China. Due to the rampant rise in the number of cases in China and globally, WHO declared COVID-19 as a pandemic on 11th March 2020. The disease is transmitted via respiratory droplets of infected patients during coughing or sneezing and affects primarily the lung parenchyma. The spectrum of clinical manifestations can be seen in COVID-19 patients ranging from asymptomatic infections to severe disease resulting in mortality. Although respiratory involvement is most common in COVID-19 patients, the virus can affect other organ systems as well. The systemic inflammation induced by the disease along with multisystem expression of Angiotensin Converting Enzyme 2 (ACE2), a receptor which allows viral entry into cells, explains the manifestation of extra-pulmonary symptoms affecting the gastrointestinal, cardiovascular, hematological, renal, musculoskeletal, and endocrine system. Here, we have reviewed the extensive literature available on COVID-19 about various clinical presentations based on the organ system involved as well as clinical presentation in specific population including children, pregnant women, and immunocompromised patients. We have also briefly discussed about the Multisystemic Inflammatory Syndrome occurring in children and adults with COVID-19. Understanding the various clinical presentations can help clinicians diagnose COVID-19 in an early stage and ensure appropriate measures to be undertaken in order to prevent further spread of the disease.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

